Differential effects of dietary protein sources on postprandial low-grade inflammation after a single high fat meal in obese non-diabetic subjects

Nutrition Journal

Volumn 10, Issue 1, 2011, Pages

  Holmer Jensen, Jens ^a   Karhu, Toni ^b   Mortensen, Lene S ^a   Pedersen, Steen B ^a   Herzig, Karl Heinz ^b   Hermansen, Kjeld ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

cytokines; dietary protein; inflammation; metabolic syndrome; nutrition; obesity; postprandial period

Indexed keywords

ADIPONECTIN; CASEIN; CYTOKINE; FISH PROTEIN; GLUTEN; MILK PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; CCL2 PROTEIN, HUMAN; CCL5 PROTEIN, HUMAN; WHEY PROTEIN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; BODY MASS; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INTERVENTION STUDY; LIPID DIET; MALE; OBESITY; POSTPRANDIAL STATE; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL; ANIMAL; ATLANTIC COD; BIOSYNTHESIS; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; FAT INTAKE; INFLAMMATION; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY;

ADIPONECTIN; ADULT; AGED; ANIMALS; CASEINS; CHEMOKINE CCL2; CHEMOKINE CCL5; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DIETARY FATS; DIETARY PROTEINS; FEMALE; GADUS MORHUA; GLUTENS; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MILK PROTEINS; OBESITY; POSTPRANDIAL PERIOD;

EID: 80054109587     PISSN: None     EISSN: 14752891     Source Type: Journal    
DOI: 10.1186/1475-2891-10-115     Document Type: Article

References (62)

1. Childhood obesity and adult morbidities. Biro FM, Wien M, Am J Clin Nutr 2010 91 1499S 1505S 10.3945/ajcn.2010.28701B 20335542
2. Comorbidities of obesity. Schelbert KB, Prim Care 2009 36 271 285 10.1016/j.pop.2009.01.009 19501243
3. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Hotamisligil GS, Shargill NS, Spiegelman BM, Science 1993 259 87 91 10.1126/science.7678183 7678183 (Pubitemid 23036092)
4. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM, JAMA 2001 286 327 334 10.1001/jama.286.3.327 11466099 (Pubitemid 32656163)
5. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Ridker PM, Buring JE, Cook NR, Rifai N, Circulation 2003 107 391 397 10.1161/01.CIR.0000055014.62083.05 12551861
6. Inflammation in atherosclerosis: from pathophysiology to practice. Libby P, Ridker PM, Hansson GK, Leducq Transatlantic Network on Atherothrombosis, J Am Coll Cardiol 2009 54 2129 2138 10.1016/j.jacc.2009.09.009 19942084
7. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V, N Engl J Med 2004 350 1387 1397 10.1056/NEJMoa032804 15070788 (Pubitemid 38419992)
8. Long-Term Interleukin-6 Levels and Subsequent Risk of Coronary Heart Disease: Two New Prospective Studies and a Systematic Review. Danesh J, Kaptoge S, Mann AG, Sarwar N, Wood A, Angleman SB, Wensley F, Higgins JP, Lennon L, Eiriksdottir G, Rumley A, Whincup PH, Lowe GD, Gudnason V, PLoS Med 2008 5 78 10.1371/journal.pmed.0050078 18399716 (Pubitemid 351649259)
9. The secretory function of adipocytes in the physiology of white adipose tissue. Wang P, Mariman E, Renes J, Keijer J, J Cell Physiol 2008 216 3 13 10.1002/jcp.21386 18264975 (Pubitemid 351813090)
10. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW, Arterioscler Thromb Vasc Biol 1999 19 972 978 10.1161/01.ATV.19.4.972 10195925 (Pubitemid 29177345)
11. The relation of body fat mass and distribution to markers of chronic inflammation. Festa A, D'Agostino R Jr, Williams K, Karter AJ, Mayer-Davis EJ, Tracy RP, Haffner SM, Int J Obes Relat Metab Disord 2001 25 1407 1415 10.1038/sj.ijo.0801792 11673759 (Pubitemid 32977855)
12. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Park HS, Park JY, Yu R, Diabetes Res Clin Pract 2005 69 29 35 10.1016/j.diabres.2004.11.007 15955385 (Pubitemid 40813409)
13. Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a review. Fain JN, Mediators Inflamm 2010 2010 513948 20508843
14. Role of MAPK phosphatase-1 in the induction of monocyte chemoattractant protein-1 during the course of adipocyte hypertrophy. Ito A, Suganami T, Miyamoto Y, Yoshimasa Y, Takeya M, Kamei Y, Ogawa Y, J Biol Chem 2007 282 25445 25452 10.1074/jbc.M701549200 17611196 (Pubitemid 47381264)
15. Monocyte chemotactic protein-1 and its role in insulin resistance. Sell H, Eckel J, Curr Opin Lipidol 2007 18 258 262 10.1097/MOL.0b013e3281338546 17495598 (Pubitemid 46743048)
16. Chemokines as risk factors for type 2 diabetes: results from the MONICA/KORA Augsburg study, 1984-2002. Herder C, Baumert J, Thorand B, Koenig W, de Jager W, Meisinger C, Illig T, Martin S, Kolb H, Diabetologia 2006 49 921 929 10.1007/s00125-006-0190-y 16532324
17. Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications. Niu J, Kolattukudy PE, Clin Sci (Lond) 2009 117 95 109 10.1042/CS20080581
18. Chemokines and cardiovascular risk. Aukrust P, Halvorsen B, Yndestad A, Ueland T, Oie E, Otterdal K, Gullestad L, Damas JK, Arterioscler Thromb Vasc Biol 2008 28 1909 1919 10.1161/ATVBAHA.107.161240 18669888
19. Activation of leukocytes by postprandial lipemia in healthy volunteers. van Oostrom AJ, Rabelink TJ, Verseyden C, Sijmonsma TP, Plokker HW, De Jaegere PP, Cabezas MC, Atherosclerosis 2004 177 175 182 10.1016/j.atherosclerosis.2004. 07.004 15488881 (Pubitemid 39361153)
20. Leukocyte Activation by Triglyceride-Rich Lipoproteins. Alipour A, van Oostrom AJ, Izraeljan A, Verseyden C, Collins JM, Frayn KN, Plokker TW, Elte JW, Cabezas MC, Arterioscler Thromb Vasc Biol 2008
21. Postprandial dietary lipid-specific effects on human peripheral blood mononuclear cell gene expression profiles. Bouwens M, Grootte Bromhaar M, Jansen J, Muller M, Afman LA, Am J Clin Nutr 2010 91 208 217 10.3945/ajcn.2009.28586 19923369
22. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Huo Y, Schober A, Forlow SB, Smith DF, Hyman MC, Jung S, Littman DR, Weber C, Ley K, Nat Med 2003 9 61 67 10.1038/nm810 12483207 (Pubitemid 36098261)
23. Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice. Koenen RR, von Hundelshausen P, Nesmelova IV, Zernecke A, Liehn EA, Sarabi A, Kramp BK, Piccinini AM, Paludan SR, Kowalska MA, Kungl AJ, Hackeng TM, Mayo KH, Weber C, Nat Med 2009 15 97 103 10.1038/nm.1898 19122657
24. Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice. Veillard NR, Kwak B, Pelli G, Mulhaupt F, James RW, Proudfoot AE, Mach F, Circ Res 2004 94 253 261 10.1161/01.RES.0000109793.17591.4E 14656931 (Pubitemid 38197459)
25. T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Wu H, Ghosh S, Perrard XD, Feng L, Garcia GE, Perrard JL, Sweeney JF, Peterson LE, Chan L, Smith CW, Ballantyne CM, Circulation 2007 115 1029 1038 10.1161/CIRCULATIONAHA.106.638379 17296858 (Pubitemid 46328297)
26. Diet and inflammation. Galland L, Nutr Clin Pract 2010 25 634 640 10.1177/0884533610385703 21139128
27. Energy intake is associated with endotoxemia in apparently healthy men. Amar J, Burcelin R, Ruidavets JB, Cani PD, Fauvel J, Alessi MC, Chamontin B, Ferrieres J, Am J Clin Nutr 2008 87 1219 1223 18469242 (Pubitemid 351679761)
28. Effect of diet-induced weight loss on plasma apelin and cytokine levels in individuals with the metabolic syndrome. Heinonen MV, Laaksonen DE, Karhu T, Karhunen L, Laitinen T, Kainulainen S, Rissanen A, Niskanen L, Herzig KH, Nutr Metab Cardiovasc Dis 2009 19 626 633 10.1016/j.numecd.2008.12.008 19278844
29. A saturated fatty acid-rich diet induces an obesity-linked proinflammatory gene expression profile in adipose tissue of subjects at risk of metabolic syndrome. van Dijk SJ, Feskens EJ, Bos MB, Hoelen DW, Heijligenberg R, Bromhaar MG, de Groot LC, de Vries JH, Muller M, Afman LA, Am J Clin Nutr 2009 90 1656 1664 10.3945/ajcn.2009.27792 19828712
30. Low-grade inflammation in individuals with the hypertriglyceridemic waist phenotype: another feature of the atherogenic dysmetabolism. Rogowski O, Shapira I, Steinvil A, Berliner S, Metabolism 2009 58 661 667 10.1016/j.metabol.2009.01.005 19375589
31. Fatty acids and postprandial inflammation. Margioris AN, Curr Opin Clin Nutr Metab Care 2009 12 129 137 10.1097/MCO.0b013e3283232a11 19202384
32. Olive oil and walnut breakfasts reduce the postprandial inflammatory response in mononuclear cells compared with a butter breakfast in healthy men. Jimenez-Gomez Y, Lopez-Miranda J, Blanco-Colio LM, Marin C, Perez-Martinez P, Ruano J, Paniagua JA, Rodriguez F, Egido J, Perez-Jimenez F, Atherosclerosis 2009 204 70 6 10.1016/j.atherosclerosis.2008.09.011 18952211
33. Effect of the fat composition of a single high-fat meal on inflammatory markers in healthy young women. Myhrstad MC, Narverud I, Telle-Hansen VH, Karhu T, Bodtker Lund D, Herzig KH, Makinen M, Halvorsen B, Retterstol K, Kirkhus B, Granlund L, Holven KB, Ulven SM, Br J Nutr 2011 1 10
34. Dietary carbohydrate intake and high-sensitivity C-reactive protein in at-risk women and men. Huffman KM, Orenduff MC, Samsa GP, Houmard JA, Kraus WE, Bales CW, Am Heart J 2007 154 962 968 10.1016/j.ahj.2007.07.009 17967604 (Pubitemid 47632496)
35. Differences in postprandial inflammatory responses to a 'modern' v. traditional meat meal: a preliminary study. Arya F, Egger S, Colquhoun D, Sullivan D, Pal S, Egger G, Br J Nutr 2010 104 724 728 10.1017/S0007114510001042 20377925
36. Effects of dairy compared with soy on oxidative and inflammatory stress in overweight and obese subjects. Zemel MB, Sun X, Sobhani T, Wilson B, Am J Clin Nutr 2010 91 16 22 10.3945/ajcn.2009.28468 19889829
37. Dairy products consumption is associated with decreased levels of inflammatory markers related to cardiovascular disease in apparently healthy adults: the ATTICA study. Panagiotakos DB, Pitsavos CH, Zampelas AD, Chrysohoou CA, Stefanadis CI, J Am Coll Nutr 2010 29 357 364 21041810
38. Glycemia and insulinemia in healthy subjects after lactose-equivalent meals of milk and other food proteins: the role of plasma amino acids and incretins. Nilsson M, Stenberg M, Frid AH, Holst JJ, Bjorck IM, Am J Clin Nutr 2004 80 1246 1253 15531672 (Pubitemid 41350685)
39. Acute effects of whey protein isolate on cardiovascular risk factors in overweight, post-menopausal women. Pal S, Ellis V, Ho S, Atherosclerosis 2010 212 339 344 10.1016/j.atherosclerosis.2010.05.032 20561625
40. Differential effects of protein quality on postprandial lipemia in response to a fat-rich meal in type 2 diabetes: comparison of whey, casein, gluten, and cod protein. Mortensen LS, Hartvigsen ML, Brader LJ, Astrup A, Schrezenmeir J, Holst JJ, Thomsen C, Hermansen K, Am J Clin Nutr 2009 90 41 48 10.3945/ajcn.2008.27281 19458012
41. Serum chemokine levels in major depressive disorder. Lehto SM, Niskanen L, Herzig KH, Tolmunen T, Huotari A, Viinamaki H, Koivumaa-Honkanen H, Honkalampi K, Ruotsalainen H, Hintikka J, Psychoneuroendocrinology 2010 35 226 232 10.1016/j.psyneuen.2009.06.007 19592174
42. Rabe-Hesketh S, Multilevel and longitudinal modeling using Stata Texas: Stata Press 2008
43. Postprandial inflammation and endothelial dysfuction. Alipour A, Elte JW, van Zaanen HC, Rietveld AP, Cabezas MC, Biochem Soc Trans 2007 35 466 469 10.1042/BST0350466 17511629 (Pubitemid 46975053)
44. Transgenic monocyte chemoattractant protein-1 (MCP-1) in pancreatic islets produces monocyte-rich insulitis without diabetes: abrogation by a second transgene expressing systemic MCP-1. Grewal IS, Rutledge BJ, Fiorillo JA, Gu L, Gladue RP, Flavell RA, Rollins BJ, J Immunol 1997 159 401 408 9200479 (Pubitemid 127493725)
45. Y-box binding protein-1 controls CC chemokine ligand-5 (CCL5) expression in smooth muscle cells and contributes to neointima formation in atherosclerosis-prone mice. Krohn R, Raffetseder U, Bot I, Zernecke A, Shagdarsuren E, Liehn EA, van Santbrink PJ, Nelson PJ, Biessen EA, Mertens PR, Weber C, Circulation 2007 116 1812 1820 10.1161/CIRCULATIONAHA.107.708016 17893273 (Pubitemid 350287106)
46. A novel RANTES antagonist prevents progression of established atherosclerotic lesions in mice. Braunersreuther V, Steffens S, Arnaud C, Pelli G, Burger F, Proudfoot A, Mach F, Arterioscler Thromb Vasc Biol 2008 28 1090 1096 10.1161/ATVBAHA.108.165423 18388327
47. Ccr5 but not Ccr1 deficiency reduces development of diet-induced atherosclerosis in mice. Braunersreuther V, Zernecke A, Arnaud C, Liehn EA, Steffens S, Shagdarsuren E, Bidzhekov K, Burger F, Pelli G, Luckow B, Mach F, Weber C, Arterioscler Thromb Vasc Biol 2007 27 373 379 17138939 (Pubitemid 46143054)
48. Raised MCP-4 levels in symptomatic carotid atherosclerosis: an inflammatory link between platelet and monocyte activation. Breland UM, Michelsen AE, Skjelland M, Folkersen L, Krohg-Sorensen K, Russell D, Ueland T, Yndestad A, Paulsson-Berne G, Damas JK, Oie E, Hansson GK, Halvorsen B, Aukrust P, Cardiovasc Res 2010 86 265 273 10.1093/cvr/cvq044 20139115
49. CC chemokine ligand-5 (CCL5/RANTES) and CC chemokine ligand-18 (CCL18/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptoms. Kraaijeveld AO, de Jager SC, de Jager WJ, Prakken BJ, McColl SR, Haspels I, Putter H, van Berkel TJ, Nagelkerken L, Jukema JW, Biessen EA, Circulation 2007 116 1931 1941 10.1161/CIRCULATIONAHA.107.706986 17909104 (Pubitemid 350287089)
50. Chemokines and left ventricular function in patients with acute myocardial infarction. Kobusiak-Prokopowicz M, Orzeszko J, Mazur G, Mysiak A, Orda A, Poreba R, Mazurek W, Eur J Intern Med 2007 18 288 294 10.1016/j.ejim.2007.02.001 17574102 (Pubitemid 46898778)
51. Chemokine receptor CCR5: from AIDS to atherosclerosis. Jones KL, Maguire JJ, Davenport AP, Br J Pharmacol 2011 162 1453 1469 10.1111/j.1476-5381.2010. 01147.x 21133894
52. High-density lipoproteins suppress chemokines and chemokine receptors in vitro and in vivo. Bursill CA, Castro ML, Beattie DT, Nakhla S, van der Vorst E, Heather AK, Barter PJ, Rye KA, Arterioscler Thromb Vasc Biol 2010 30 1773 1778 10.1161/ATVBAHA.110.211342 20702809
53. Systemic immune mediators and lifestyle changes in the prevention of type 2 diabetes: results from the Finnish Diabetes Prevention Study. Herder C, Peltonen M, Koenig W, Kraft I, Muller-Scholze S, Martin S, Lakka T, Ilanne-Parikka P, Eriksson JG, Hamalainen H, Keinanen-Kiukaanniemi S, Valle TT, Uusitupa M, Lindstrom J, Kolb H, Tuomilehto J, Diabetes 2006 55 2340 2346 10.2337/db05-1320 16873699 (Pubitemid 44743633)
54. Omega-3 fatty acids and the regulation of expression of endothelial pro-atherogenic and pro-inflammatory genes. De Caterina R, Massaro M, J Membr Biol 2005 206 103 116 10.1007/s00232-005-0783-2 16456721 (Pubitemid 43199144)
55. Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids. Adkins Y, Kelley DS, J Nutr Biochem 2010 21 781 792 10.1016/j.jnutbio.2009.12.004 20382009
56. Bioactive milk peptides: a prospectus. Clare DA, Swaisgood HE, J Dairy Sci 2000 83 1187 1195 10.3168/jds.S0022-0302(00)74983-6 10877382
57. Inhibition of proliferative responses of mouse spleen lymphocytes and rabbit Peyer's patch cells by bovine milk caseins and their digests. Otani H, Hata I, J Dairy Res 1995 62 339 348 10.1017/S0022029900031034 7601978
58. Casein-derived tripeptide, Val-Pro-Pro (VPP), modulates monocyte adhesion to vascular endothelium. Aihara K, Ishii H, Yoshida M, J Atheroscler Thromb 2009 16 594 603 10.5551/jat.729 19907102
59. Casein alpha s1 is expressed by human monocytes and upregulates the production of GM-CSF via p38 MAPK. Vordenbaumen S, Braukmann A, Petermann K, Scharf A, Bleck E, von Mikecz A, Jose J, Schneider M, J Immunol 2011 186 592 601 10.4049/jimmunol.1001461 21135174
60. Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? Dandona P, Aljada A, Mohanty P, Ghanim H, Hamouda W, Assian E, Ahmad S, J Clin Endocrinol Metab 2001 86 3257 3265 10.1210/jc.86.7.3257 11443198 (Pubitemid 32674120)
61. Insulin inhibits NFkappaB and MCP-1 expression in human aortic endothelial cells. Aljada A, Ghanim H, Saadeh R, Dandona P, J Clin Endocrinol Metab 2001 86 450 453 10.1210/jc.86.1.450 11232040 (Pubitemid 32109834)
62. Suppressive effect of insulin infusion on chemokines and chemokine receptors. Ghanim H, Korzeniewski K, Sia CL, Abuaysheh S, Lohano T, Chaudhuri A, Dandona P, Diabetes Care 2010 33 1103 1108 10.2337/dc09-2193 20200310